If any a licensee fails to make such payment as provided in section 457, subsection 1, paragraph B, that licensee, by reason of the nonpayment is in default as to all producers or licensees whose accounts then remain unpaid and the bond provided for shall must be forfeited to the extent of all sums then due from the licensee to the producers or licensees. Whenever the commissioner determines that a licensee has failed to make payment, he the commissioner shall provide notice, in a manner consistent with the rule-making provisions of the Maine Administrative Procedure Act, provide notice that payment under the bond will be sought and indicating the time within which other producer or licensee claims may be made known to him the commissioner. Upon determination of the commissioner that there has been a default in payment by a licensee, the conditions of the bond shall be are deemed to be broken and the commissioner may bring action on the defaulted bond for the benefit of producers or licensees. Whenever the amount of the bond is not sufficient to cover all valid claims, the commissioner shall distribute the amount available on a pro rata basis.

Sec. 16. 7 MRSA §481 is repealed.

Sec. 17. 7 MRSA §482, first ¶ is amended to read:

No A person shall may not manufacture, sell, distribute, transport, offer or expose for sale, distribution or transportation any article of commercial feeding stuff, commercial fertilizer, drug or food which that is adulterated or misbranded within the meaning of this Title chapter or chapter 103.

Sec. 18. 7 MRSA §483 is amended to read:

§483. Adulteration

For the purpose of this Title an article shall be deemed to be adulterated chapter and chapter 103, unless the term is more specifically defined, "adulterated" means made impure or inferior by adding extraneous ingredients:.

1. Drug. In case of a drug:

A. If, when a drug is sold under or by a name recognized in the United States pharmacopoeia or national formulary, it differs from the standard of strength, quality or purity as laid down in the United States pharmacopoeia or national formulary official at the time of investigation, or as fixed